![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/3/2021 06:06 | RNS Number : 7104T Motif Bio PLC 29 March 2021 Motif Bio plc ("Motif" or the "Company") Update re proposed Reverse Takeover Motif Bio plc (AIM: MTFB), which has been reclassified as an AIM Rule 15 cash shell, provides a further update regarding the proposed reverse takeover pursuant to AIM Rule 14 ("Reverse Takeover") that was outlined in the Company's announcements of 5 January 2021 and 27 January 2021. Motif continues to progress a Reverse Takeover under a heads of terms agreement with a UK-based ADC (Antibody-Drug Conjugate) discovery and development company (the "Target"), as a result of which, subject to, among other matters, the execution of a sale and purchase agreement, Motif would acquire the entire issued share capital of the Target (the "Proposed Transaction"). Motif will remain suspended from trading while the Proposed Transaction is negotiated and advanced, and the Company will provide shareholders with further updates as appropriate. Many of the key work streams of the Proposed Transaction are now substantially complete. However, as a result of additional audit work which is required for the year ended 31 December 2020, marketing is now not expected to commence until the second half of April 2021. As such, should the Proposed Transaction proceed, it is expected that Motif will now publish the AIM Admission Document in late April or early May 2021. At present there can be no assurances that Motif will be able to complete the Proposed Transaction and as a consequence the Company's admission to trading on AIM may be cancelled. The person responsible for the release of this announcement on behalf of Motif is Jonathan Gold, President and Chief Business Officer. | ![]() moneymunch | |
27/3/2021 10:01 | The Ides of March are upon us - time to settle some debts as the Romans would say | ![]() scottdavid70 | |
27/3/2021 07:57 | What rns dont see anything since 26 th | ![]() tnt99 | |
27/3/2021 01:55 | Do you mean the TOR? | small crow | |
26/3/2021 22:47 | Not rot RTO | ![]() tnt99 | |
26/3/2021 22:45 | Weird the shares I bought which reappeared on my Hargreaves Lansdown account all be it with a zero value have been taken off again This is either likely the end for my small holding or ready for the rotWhat do you think | ![]() tnt99 | |
26/3/2021 08:08 | We deserved better We wanted Sir Winston Churchill and we got George Galloway | ![]() scottdavid70 | |
24/3/2021 10:47 | Change is afoot with investment banks being told they need to take shares in new IPO’s to align interests We can continue ramming that message home here with a NO VOTE! | ![]() scottdavid70 | |
24/3/2021 10:45 | Kind of crazy what investors will take. More than likely the take home pay with zero risk for Gold and Lumsden will be 25% plus of the value of the ENTIRE NEW COMPANY VALUATION on RTO if investors vote it through. Personally I won’t accept these crumbs along with what has happened with Iclaprim and Orange Avenue Technologies LLC. It’s grotesque greed for me and a message needs to be sent that investors have a strong voice | ![]() scottdavid70 | |
24/3/2021 10:12 | All this waiting for a company that will be valued under £2 million and the main asset Iclaprim syphoned to a company nobody can find so therefore the upside for investors being clouded in secrecy. The only thing the Directors have been specialists in is filling their own BANK accounts and it still hasn’t stopped | ![]() scottdavid70 | |
24/3/2021 07:43 | The only upcoming news here is delist. No RTO or anything else of value. | ![]() perfectstorm | |
23/3/2021 09:44 | See people on LSE are finally getting the message about Lumsden. 5 years at his new company - plenty of fundraising with his salary attached to it - then rinse and repeat year on year - matters not where he succeeds or not as he will have trousered millions in salary before perhaps exiting stage left having failed with a BONUS Can’t write it but you know it’s going to happen | ![]() scottdavid70 | |
22/3/2021 16:16 | Most people on LSE are asking about a bus but haven’t cottoned on this is the Italian job in a van | ![]() scottdavid70 | |
22/3/2021 09:39 | Remember all they have told you and what has happened especially by Lumsden but now we are told an appropriate level on consolidation and a fundraise. I have told you I see 75% consolidation and £45 million fundraise which will be apocalyptic for more dilution - not that we haven’t suffered enough - place your bets but that’s the dystopian future I see for shareholders here with this set of Directors whom only need a RTO to happen as their shareholding’s are less than many ordinary hard working investors | ![]() scottdavid70 | |
21/3/2021 22:14 | Doesn’t really matter when news comes as it will be so underwhelming you will find it hard to understand why it took so long to do the deal. So Tuesday or next week it will bring this whole sorry saga to a vote. Then we can decide how it closes - either with further enrichment of the Directors to our detriment or one bloody nose finally for them. Personally I think there is as much change of a Tuesday RNS as there is of anyone finding out where Orange Avenue Technologies LLC is based and who is in on the Board. ZERO CHANCE as Gold still needs his extra £50,000 for pushing this into April | ![]() scottdavid70 | |
21/3/2021 18:06 | I'm expecting new on Tuesday just to catch people out | ![]() petersmith6 | |
21/3/2021 16:20 | Realised I just put last weekend - guaranteed this isn’t the weekend before any news - Gold has to get his £50,000 extra gold bars on the 1st April so quiet week next week for sure Sorry for any confusion | ![]() scottdavid70 | |
21/3/2021 08:59 | Last weekend for Motif Bio holders before the veil of hopelessness is pulled across to expose what crumbs shareholders have been left with. It won’t be pretty but they will be banking on your something better nothing when filling their personal pockets when the RTO happens. You can choose to not make that last act of greed happen | ![]() scottdavid70 | |
21/3/2021 08:47 | THINK ABOUT IT You are SELLING your house do you - A) Stop all advertising and go invisible about your house OR B) advertise the hell out of it and all it’s great attributes Motif Bio and its Directors haven’t promoted it once - nothing at all Anyone else find that a little strange? When the EMA submission was pulled and the HARP trials cancelled but we were informed in a investors presentation that we needed to find the information in - we knew it wasn’t good news- so it proved to be Same here - Orange Avenue Technologies LLC has been set up to hide what’s going on with Iclaprim- we need to find out who truly benefits from this transaction | ![]() scottdavid70 | |
20/3/2021 22:25 | The whole news blackout and lack of promised updates - see Lemellar and Iclaprim- with Iclaprim is for me a calculated plan from the Board. Make Iclaprim seem worthless - set up a invisible company with “supposedly Screw that for a laugh - let’s make as much noise about Iclaprim ~ Orange Avenue Technologies LLC and the company no one wants to admit exists. What’s going on Graham Lumsden - Jonathon Gold - Chris Wardhaugh? Let’s make everyone aware of the shenanigans we as hard working ordinary investors are having to deal with here for the past 2 plus years | ![]() scottdavid70 | |
19/3/2021 17:37 | Good for you Chuffer - Karma can take its time but she usuyshows up - these Board members have an interesting future if that’s the case BTW - have a I mentioned the new Chapter on Orange Avenue Technologies LLC yet??? | ![]() scottdavid70 | |
19/3/2021 10:40 | Amazing how Motif Bio do it want to update their legacy asset as to letting everyone know that Iclaprim is now owned by Orange Avenue Technologies LLC and also John Palmer on LinkedIn isn’t letting anyone know he is the “100%” owner of Orange Avenue Technologies LLC Why???????? Think we all know why... | ![]() scottdavid70 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions